peHUB and peHUB Wire Will Continue After Primack Leaves

Big news in the world of venture capital and private equity media and PR: Dan Primack, author of the peHUB Wire daily email newsletter and creator of its web site, peHUB, is leaving Thomson Reuters to create a similar offering for CNN Money's soon-to-be-revamped Fortune.com site.

Over the past several years, Primack has become arguably the single most important journalist covering VC and PE, largely through his excellent work first on the daily newsletter and then on the web site. Lots of people in the industry can pick a beef with Dan over the way he has portrayed certain news or his tenacity in covering things that they would have rather not had covered, but he has proven himself to be a thorough, dogged and very hard-working reporter.

Now he moves on to Fortune.com, where he will be covering not only VC and PE but also Wall Street and M&A through a daily email called "The Term Sheet" and a sister web site. He starts on Sept.7, the day after Labor Day.

While all the other coverage I've seen on the web has focused on Primack's move to Fortune and the CNN.com web site, my key question was about the VC/PE daily newsletter and the web site. Would they continue without Primack, who once wrote about creating the newsletter simply to raise a small amount of advertising money to fund a pet project, and has been both the brains and the brawn behind it ever since?

Larry Aragon, editor-in-chief of Thomson Reuter's Private Equity Week and VC Journal (the print/online pubs that spawned peHUB), emailed me that yes, they would both continue after Dan leaves next Thursday, though he did not identify who would be staffing them. They know they have some big shoes to fill, and it's not a slam-dunk that peHUB will be as strong, or as vital a read, as it is are now.

From a VC/PE media relations standpoint, however, this is great news -- Primack is going to bring his coverage of VC and PE over to the huge CNN.com web site, while Thomson Reuters will continue to have its offering.

Here's some other coverage on the web so far:

Statements from Fortune.com and Primack

Interview with Dan Roth of Fortune.com about Primack

Betnovate

Voltaren